The biologics landscape in Seoul and its surrounding metropolitan area, including the Songdo Bio Cluster, has transformed into one of the world's most dense and technologically advanced biopharmaceutical hubs. As a premier Biologics Drugs Factory & Supplier in Seoul, the region benefits from an unparalleled synergy between government support, world-class research universities, and industrial giants. South Korea's "K-Bio" initiative has propelled Seoul into the spotlight for CDMO (Contract Development and Manufacturing Organization) excellence, particularly in monoclonal antibodies, recombinant proteins, and the burgeoning field of mRNA vaccines.
Suppliers in Seoul are renowned for their strict adherence to international standards such as GMP, ISO, and CE, making them preferred partners for global pharmaceutical companies. The city's infrastructure supports everything from early-stage R&D in Gangnam and Guro Digital Complex to mass production in the specialized zones nearby. This unique ecosystem ensures that every phase of biologic drug development—from formulation mixing to aseptic filling and cold chain logistics—is handled with precision and innovation.
Biotech Startups
Global CDMO Capacity
Annual Bio Export
Standardized Compliance
Seoul is increasingly focusing on personalized medicine. Factories are integrating modular cleanrooms and single-use systems to handle the high sensitivity of cell-based therapies. Local suppliers are providing advanced bioreactors that allow for rapid scaling of chimeric antigen receptor (CAR) T-cell therapies.
Post-pandemic, the demand for mRNA platforms has surged. Seoul-based suppliers offer specialized lipid nanoparticle (LNP) formulation tanks and high-speed prefilled syringe lines specifically designed for heat-sensitive mRNA biologics.
The integration of AI and IoT in Seoul's drug factories allows for real-time monitoring of fermentation processes. Our advanced osmometers and mixing systems are now equipped with data logging capabilities to ensure "Quality by Design" (QbD) compliance demanded by global regulators like the FDA and EMA.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Connection to Seoul: Internationally, we have long-term trade relations with India, Southeast Asia, South Korea (Seoul), Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese and South Korean markets.
Our drugs and intermediates are widely used across the bio-industrial landscape in Seoul:
We supply and assemble high-capacity systems for the Seoul market:
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For main product intermediates, we maximize advantages to meet the requirements of most customers and complete tasks within specified time limits.
When searching for a Biologics Drugs Factory in Seoul, one must consider the intricate logistics involved in cross-border trade between China and Korea. Hangzhou Jeci Biochem serves as a vital bridge, ensuring that high-purity intermediates reach the state-of-the-art facilities in Seoul's Digital Media City or the Teheran-ro biotech corridor. The integration of Marya systems into local factories has streamlined the production of complex vaccines, while our CE approved mixing tanks provide the reliability needed for long-term clinical trials.
Furthermore, the localized application scenarios for biologic drugs in Seoul are diverse. From advanced oncology treatments at the Seoul National University Hospital to innovative aesthetics and dermatology solutions developed in Gangnam-gu, the demand for high-quality formulation vessels and sterile filling lines is constant. Our single-use disposable fluid path systems are particularly popular among Seoul's R&D startups looking to minimize cross-contamination risks and reduce cleaning validation times.
The role of Suppliers in Seoul also extends to specialized storage. Given the high real estate costs in the capital, our Compact Cold Storage Racking and Mobile Shelving systems are essential for maximizing the footprint of pharmaceutical warehouses. These systems, combined with advanced freeze-drying capacity ranging from 30kg to 300kg, ensure that biologics maintain their potency from the factory floor to the patient.
As we look to the future, the Seoul biologics market is set to expand into biosimilars for rare diseases. This requires even more precise equipment, such as our customized bio engineering fermenters and aseptic vial filling machines. By choosing a partner with deep roots in both the Chinese manufacturing power and the Korean innovation ecosystem, companies can ensure they are at the forefront of the global biologic revolution.
SJ medical
